|
T.ONC
|
http://cancergrace.org/lung/2009/10/30/avastin-vanderbilt-phase-ii/
|
|
T.ONC
|
I would like to expand my comments on the Squamous cell indications. I...
|
|
T.ONC
|
I find the presentation reasurring, He said the US, UK and Belgium all...
|
|
T.ONC
|
Conference call on August 10, I expect an update on enrollment in phase III...
|
|
T.ONC
|
This last post makes more sense to me, and you are just asking to much at...
|
|
T.ONC
|
Their are a number of shallow statements in your post. Chemotherapy cocktails...
|
|
T.ONC
|
Over on Yahoo they seem to be confused about where we are on enrollment, some...
|
|
T.ONC
|
I find it hard to understand when so many phase III trials fail and now this...
|
|
T.ONC
|
As I have said in past years this stock usually goes into a coma after ASCO...
|
|
T.ONC
|
Long long way from even knowing if it would work in humans but I found it...
|
|
T.ONC
|
I just want to explain that first statement about the 7:40 mark, he explained...
|
|
T.ONC
|
A few more comments, 7.40 mark talks about UK trial and non-evaluable...
|
|
T.ONC
|
Actually he said 40,000 would be the bottom end, it all depends on how well...
|
|
T.ONC
|
This is a great call at least for Brad! He says a lot, the audio quality is...
|
|
T.ONC
|
Finally listened to the conference call, nothing Brad said would have pushed...
|
|
T.ONC
|
Another promising drug for four percent of the lung cancer patients. Not a...
|
|
T.ONC
|
With Biovex and now this things are looking up for Melanoma patients. The...
|
|
T.ONC
|
http://finance.yahoo.com/news/Oncolytics-BiotechR-Inc-To-prnews-1340957357...
|
|
T.ONC
|
http://myeloma.org/ArticlePage.action?tabId=4&menuId=7&articleId=2901...
|
|
T.ONC
|
Actually I agree today smelled like manipulation by some firm that wants it...
|